Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Farmers Insurance
Express Scripts
Johnson and Johnson
Harvard Business School
McKinsey
Covington
Federal Trade Commission
QuintilesIMS

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,929,629

« Back to Dashboard

Summary for Patent: 4,929,629
Title: Therapeutic compound
Abstract:N,N-Dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride monohydrate is a non-hygroscopic material which can be used as a pharmaceutical in the treatment of depression.
Inventor(s): Jeffery; James E. (Nottingham, GB2)
Assignee: Boots Company, PLC (Nottingham, GB2)
Application Number:07/342,638
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 4,929,629

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,929,629

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8531071Dec 17, 1985

International Family Members for US Patent 4,929,629

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 56942 ➤ Try a Free Trial
Australia 601167 ➤ Try a Free Trial
Australia 6644286 ➤ Try a Free Trial
Canada 1266278 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Julphar
QuintilesIMS
Boehringer Ingelheim
Cipla
Deloitte
Mallinckrodt
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.